Global Hemoglobin Testing Market 2016-2020

  • ID: 3769491
  • Report
  • Region: Global
  • 73 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bayer Medical Care
  • DiaSys Diagnostic Systems
  • Erba Diagnostics
  • Masimo
  • Roche Diagnostics
  • MORE
About the Hemoglobin Testing Market

The red blood cells in the bloodstream carry a protein known as hemoglobin, which helps to transport oxygen throughout the body. Hemoglobin tests are conducted to detect the quantity of hemoglobin present in the blood. These tests are often done as a part of complete blood count during a routine health check-up or at the time of any illness to determine the type of anemia, which occurs due to low count of red blood cells.

Studies estimated that worldwide around 416 million people were living with diabetes in 2015. Out of which, around 46% of them, i.e., 191.3 million people, were not diagnosed with this disease, owing to lack of awareness. Diabetes and anemia are not directly linked, but studies reveal that around 26% of people with diabetes are diagnosed with anemia. Kidney damage or chronic kidney disease is a common condition observed in people with chronic diabetes.

The analysts forecast the global hemoglobin testing market to grow at a CAGR of 10.58% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global hemoglobin testing market for 2016-2020. To calculate the market size, we use revenue generated from the sales of various types of hemoglobin testing equipment and consumables.

The market is divided into the following segments based on geography:

- Americas
- APAC
- EMEA

The report, Global Hemoglobin Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott Diagnostics
- Alere
- Danaher
- EKF Diagnostics Holdings
- Roche Diagnostics

Other prominent vendors
- ACON Laboratories
- ARKRAY
- Bayer Medical Care
- Bio-Rad Laboratories
- Daiichi Biotech
- DiaSys Diagnostic Systems
- Diazyme Laboratories
- Epinex Diagnostics
- Erba Diagnostics
- Fisher Scientific
- GREEN CROSS MEDIS
- HORIBA
- HUMAN Gesellschaft für Biochemica und Diagnostica
- Masimo
- Mindray Medical International
- OrSense
- PTS Diagnostics
- Randox Laboratories
- Sebia
- Siemens Healthcare
- Sysmex
- TaiDoc Technology
- Tosoh Bioscience
- Trinity Biotech
- Una Health

Market drivers
- Development and launch of novel hemoglobin testing devices

Market challenges
- High cost and maintenance of hemoglobin testing

Market trends
- Direct-to-consumer testing

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bayer Medical Care
  • DiaSys Diagnostic Systems
  • Erba Diagnostics
  • Masimo
  • Roche Diagnostics
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
  • Invasive method
  • Non-invasive method
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Global hemoglobin testing equipment market
  • Global hemoglobin testing reagents and consumables market
PART 07: Market segmentation by technology
  • Chromatography
  • Immunoassay
  • Other
PART 08: Market segmentation by end-user
  • Laboratories
  • Hospitals
  • Research centers
PART 09: Geographical segmentation
  • Hemoglobin testing market in Americas
  • Reimbursement by Medicare in US
  • Hemoglobin testing market in EMEA
  • Hemoglobin testing market in APAC
PART 10: Market drivers
  • Increasing incidence of diabetes and popularity of HbA1c tests
  • Favorable reimbursement of hemoglobin testing
  • Development and launch of novel hemoglobin testing devices
PART 11: Impact of drivers

PART 12: Market challenges
  • High cost and maintenance of hemoglobin testing
  • Stringent regulatory issues
  • Threat of substitute products
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Shift from centralized laboratory to POCT
  • Increased mergers and acquisition (M&A)
  • Direct-to-consumer testing
PART 15: Vendor landscape
  • Competitive scenario
PART 16: Key vendor profiles
  • Abbott Diagnostics
  • Alere
  • Danaher
  • EKF Diagnostics Holdings
  • Roche Diagnostics
  • Other prominent vendors
PART 17: Appendix
  • List of abbreviations
PART 18: About the Author

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Types of hemoglobin testing methods
Exhibit 03: Global hemoglobin testing market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global hemoglobin testing market segmentation based on product
Exhibit 06: Global hemoglobin testing market segmentation based on product 2015
Exhibit 07: Global hemoglobin testing market segmentation based on product 2020
Exhibit 08: Global hemoglobin testing equipment market 2015
Exhibit 09: Global hemoglobin testing equipment market 2020
Exhibit 10: Global hemoglobin testing equipment market 2015-2020 ($ millions)
Exhibit 11: Global laboratory testing market 2015-2020 ($ millions)
Exhibit 12: Global POCT equipment market 2015-2020 ($ millions)
Exhibit 13: Global hemoglobin testing reagent and consumables market 2015-2020 ($ billions)
Exhibit 14: Segmentation of global hemoglobin testing market by product
Exhibit 15: Segmentation of global hemoglobin testing market by product ($ millions)
Exhibit 16: Segmentation of global hemoglobin testing market by technology 2015
Exhibit 17: Segmentation of global hemoglobin testing market by end-user 2015
Exhibit 18: Segmentation of global hemoglobin testing market by geography 2015
Exhibit 19: Segmentation of global hemoglobin testing market by geography 2020
Exhibit 20: Hemoglobinin testing market in Americas 2015-2020 ($ millions)
Exhibit 21: Selected laboratory service with national limitation amount (NLA) provided by Medicare
Exhibit 22: Estimation of few diseases in US
Exhibit 23: Hemoglobin testing market in EMEA 2015-2020 ($ millions)
Exhibit 24: Hemoglobin testing market in APAC 2015-2020 ($ millions)
Exhibit 25: Segmentation of global hemoglobin testing market by geography
Exhibit 26: Segmentation of global hemoglobin testing market by geography ($ millions)
Exhibit 27: Impact of drivers
Exhibit 28: Impact of drivers and challenges
Exhibit 29: Abbott Diagnostics: Key takeaways
Exhibit 30: Alere: Business segmentation by revenue 2014
Exhibit 31: Alere: Cardiometabolic division revenue and YoY growth rate 2012-2014 ($ millions)
Exhibit 32: Alere: Key takeaways
Exhibit 33: Danaher: Key takeaways
Exhibit 34: EKF Diagnostics: Business segmentation by revenue 2014
Exhibit 35: EKF Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 36: EKF Diagnostics Holdings: Key takeaways
Exhibit 37: Roche Diagnostics: Business segmentation by revenue 2015
Exhibit 38: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2015
Exhibit 39: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 40: Roche Diagnostics: Diabetes care - YoY revenue and growth rate ($ billions)
Exhibit 41: Roche Diagnostics: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Diagnostics
  • Bayer Medical Care
  • DiaSys Diagnostic Systems
  • Erba Diagnostics
  • Masimo
  • Roche Diagnostics
  • MORE
New Report Released: - Global Hemoglobin Testing Market 2016-2020

The author of the report recognizes the following companies as the key players in the global hemoglobin testing market: Abbott Diagnostics, Alere, Danaher, EKF Diagnostics Holdings, and Roche Diagnostics.

Other Prominent Vendors in the market are: ACON Laboratories, ARKRAY, Bayer Medical Care, Bio-Rad Laboratories, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories, Epinex Diagnostics, Erba Diagnostics, Fisher Scientific, GREEN CROSS MEDIS, HORIBA, HUMAN Gesellschaft für Biochemica und Diagnostica, Masimo, Mindray Medical International, OrSense, PTS Diagnostics, Randox Laboratories, Sebia, Siemens Healthcare, Sysmex, TaiDoc Technology, Tosoh Bioscience, Trinity Biotech, and Una Health.

Commenting on the report, an analyst from the research team said: “A trend which is boosting market growth is the shift from centralized laboratory use to POCT. The centralized hemoglobin testing methods are useful to diagnose people with diabetes and anemia. However, the time required for the sample analysis is more, and this adds up the time for diagnosis. This drawback of centralized testing has shifted the blood sample analysis to POCT, where the results are provided instantly in the POC settings. This assists physicians in the immediate diagnosis of disease, thereby initiating effective treatment strategies. The POC hemoglobin testing devices are useful, particularly in people with anemia, to check the hemoglobin variants and HbA1c levels.”

According to the report, a key growth driver is the development and launch of novel testing devices by vendors. Development in hemoglobin testing has offered many advantages in the clinical diagnosis methods. Manufacturers develop and launch innovative products in the market, which helps them penetrate the market. For instance, manufacturers are focused on developing hemoglobin test devices that can be used at home settings. In addition, vendors are developing compact and portable devices, which require less space and can be transferred easily during emergency situations.

Further, the report states that one challenge that could hamper market growth is the high cost and maintenance of hemoglobin testing. In the case of POC analyzers it is mandatory to maintain the products with correct functioning to obtain accurate results. Also, storage conditions of blood testing strips and operator's performance need to be checked continuously. The

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Diagnostics
- Alere
- Danaher
- EKF Diagnostics Holdings
- Roche Diagnostics
- ACON Laboratories
- ARKRAY
- Bayer Medical Care
- Bio-Rad Laboratories
- Daiichi Biotech
- DiaSys Diagnostic Systems
- Diazyme Laboratories
- Epinex Diagnostics
- Erba Diagnostics
- Fisher Scientific
- GREEN CROSS MEDIS
- HORIBA
- HUMAN Gesellschaft für Biochemica und Diagnostica
- Masimo
- Mindray Medical International
- OrSense
- PTS Diagnostics
- Randox Laboratories
- Sebia
- Siemens Healthcare
- Sysmex
- TaiDoc Technology
- Tosoh Bioscience
- Trinity Biotech
- Una Health.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll